Trials / Sponsors / Peter Siesjö
Peter Siesjö
Academic / Other · 7 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma Glioblastoma | Phase 2 | 2024-10-07 |
| Recruiting | Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema Glioblastoma, Cerebral Metastases, Meningioma | Phase 2 | 2024-01-27 |
| Recruiting | Antisecretory Factor Glioblastoma Phase 2 Glioblastoma | Phase 2 / Phase 3 | 2024-01-15 |
| Recruiting | Antisecretory Factor In Severe Traumatic Brain Injury Traumatic Brain Injury | Phase 2 | 2020-03-10 |
| Completed | Antisecretory Factor in Primary Glioblastoma 1 Glioblastoma, Cerebral Edema, Chemotherapy Effect | Phase 1 / Phase 2 | 2019-09-01 |
| Withdrawn | Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Head Trauma, Intensive Care Neurological Disorder, Edema Brain | Phase 2 | 2018-03-01 |
| Completed | Effect of Antisecretory Factor, Given as a Food Supplement to Adult Patients With Severe Traumatic Brain Injur Brain Trauma | Phase 3 | 2017-09-17 |